Money & Markets

TP ICAP Trades at 1.3x Core EBIT: Chart Analysis Sees 532 GBX Target

TP ICAP's core broking trades at 1.3x EBIT after stripping out Parameta's £1.9bn value; a 7.0x re-rating implies 532 GBX, 68% above 317.2 GBX.

By Amara Osei

3 min read

Assumptions
AssumptionsTheInvestorPost / pixabay

What's News

  • TP ICAP's core broking businesses are valued at 1.3x EBIT (£272M EBIT) after subtracting Parameta's £1.9bn valuation from the £2.26bn market cap.
  • A 7.0x EBIT re-rating implies SOTP fair value of ~532.2 GBX per share, +67.8% from the current 317.2 GBX.
  • Bear case (5.0x, Parameta £1,700M) implies 427.8 GBX (+34.9%); bull case (9.0x, Parameta £2,100M) implies 636.5 GBX (+100.7%).
  • The analysis uses ~712.9 million active shares and ~£10 million in net debt.
  • The scenario table was published by TradingView user JarvisTan on a TCAP chart idea.

TP ICAP's core broking businesses trade at just 1.3x EBIT once Parameta Solutions is stripped out, according to a valuation analysis published on TradingView under the byline JarvisTan. Apply a normal interdealer broker multiple of 7.0x, and the implied Sum-of-the-Parts fair value climbs to roughly 532 GBX per share — 68% upside from the current price of 317.2 GBX.

The analysis, posted alongside a chart of TP ICAP Group plc (LSE_DLY:TCAP), rests on a simple piece of arithmetic. TP ICAP's market cap sits at £2.26 billion. Parameta, the group's data and analytics arm, carries a standalone valuation of £1.9 billion. Subtract one from the other and the market is paying about £360 million for core broking divisions that generate roughly £272 million in EBIT — an implied multiple of just 1.3x earnings before interest and tax.

That's the gap JarvisTan sets out to price.

How does the math work?

The analysis uses roughly 712.9 million active shares, excluding treasury stock, and assumes about £10 million in net debt. Those inputs feed three Sum-of-the-Parts scenarios that vary Parameta's worth and the multiple applied to core broking EBIT.

The scenarios look like this:

  • Conservative (Bear): Parameta at £1,700M, core broking at 5.0x (£1,360M), total implied equity value £3,050M — 427.8 GBX per share, or +34.9% versus 317.2 GBX.
  • Base Case (Industry Average): Parameta at £1,900M, core broking at 7.0x (£1,904M), total implied equity value £3,794M — 532.2 GBX per share, or +67.8%.
  • Bull Case (Full Re-rating): Parameta at £2,100M, core broking at 9.0x (£2,448M), total implied equity value £4,538M — 636.5 GBX per share, or +100.7%.

Even the bear case, in other words, implies more than a third of upside from the current share price.

What's the assumption behind the 7.0x multiple?

The base case rests on the idea that interdealer brokers deserve a standard industry multiple of 7.0x EBIT. TP ICAP's core divisions don't trade anywhere near that today, at the analysis's inferred 1.3x. The title of the piece — "Assumptions" — signals exactly where the risk sits: if the market refuses to re-rate the broking businesses, or if Parameta's £1.9 billion standalone figure proves rich, the 532 GBX target doesn't materialize.

The bull case requires more — a full re-rating to 9.0x on core broking plus a £200 million uplift in Parameta's valuation to £2,100 million. That combination roughly doubles the share price to 636.5 GBX.

The conservative scenario shows the downside of the thesis is still, on the author's numbers, upside: 5.0x on £272 million of EBIT plus a lower £1,700 million Parameta value still yields 427.8 GBX.

What should investors watch?

The whole construction hinges on two numbers: Parameta's standalone worth and the EBIT multiple the market will eventually grant the rump broking business. JarvisTan's scenarios bracket those inputs between £1.7 billion and £2.1 billion for Parameta, and between 5.0x and 9.0x for core broking. Any separation, spin-off or segment disclosure that crystallizes Parameta's valuation would force the market to mark the remaining business explicitly — and, on this analysis, that marking points well above 317.2 GBX.

Note this is a retail-authored TradingView idea, not a broker note or company guidance, and its figures carry no assurance. But the framework is transparent: 712.9 million shares, £10 million net debt, £272 million EBIT. Investors can stress every input themselves before deciding whether the market is mispricing TP ICAP's core business or simply pricing risks the chart leaves out.

Source: tradingview.com

Share this article:

More from Amara Osei

Amara Osei

Show full bio

Senior reporter covering companies, deals and strategy in entrepreneurship, startups and venture funding at Business Bearings.

2,136 articles

Related articles

« Previous articleNext article »